manejo del paciente con dispepsia - Instituto Guatemalteco de ...

More documents

Recommendations

Info

26. Kay L, Jorgensen T. Epidemiology of upper dyspepsia in random population.Prevalence, incidence, natural history and risk factors. Scan J Gastroenterol 1994;29: 1-7.27. Yuyuan LI, Yuqiang NIE, Weihong SHA, Hua SU. The link between socialpsychosocial and functional dyspepsia: An epidemiological study. Chin Med J 2002;115: 1.082-1.084.28. Stanghellini V. Relationship between upper gastrointestinal symptoms andlifestyle, psychosocial factors and comorbidity in the general population: results fromthe Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand JGastroenterol Suppl 1999; 231: 29-37.29. Pantoflickova D, Blum AL, Koelz HR. Helicobacter pylori and functionaldyspepsia: a real causal link? Bailleres Clin Gastroenterol 1998; 12: 503-532.30. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review ofthe epidemiological evidence on Helicobacter pylori infection and nonulcer oruninvestigated dyspepsia. Arch Intern Med 2000; 160: 1.192-1.198.31. Bazzoli F, De Luca L, Pozzato P, Zagari RM, Fossi S, Ricciardiello L et al.Helicobacter pylori and functional dyspepsia: review of previous studies andcommentary on new data. Gut 2002; 50 (Supl. 4): 33-35.32. Elta GH, Behler EM, Colturi TJ. Comparison of coffee intake and coffee-inducedsymptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls.Am J Gastroenterol 1990; 85: 1.339-1.342.33. Nandurkar S, Talley NJ, Xia H, Mitchell H., Hazel S, Jones M. Dyspepsia in thecommunity is linked to smoking and aspirin use but not to Helicobacter pyloriinfection. Arch Intern Med 1998; 158: 1.427-1.433.34. Woodward M, Morrison CE, McColl Ke. The prevalence of dyspepsia and use ofantisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestylefactors. Aliment Pharmacology 1999; 13: 1.505-1.509.35. Biter P, Howell S, Lemon M, Young LJ, Jones MP, Talley NJ. Low socioeconomicclass is a risk factor for upper and lower gastrointestinal symptoms: a populationbased study in 15000 Australian adults. Gut 2001; 49: 66-67.36. Talley NJ, Weaver AL, Zinsmeister AR. Smoking, alcohol, and nonsteroidal antiinflammatorydrugs in outpatients with functional dyspepsia and among dyspepsiasubgroups. Am J Gastroenterol 1994; 89: 524-528.37. Talley NJ, McNeilD. Piper DW. Environmental factors and chronic unexplaineddyspepsia. Association with acetaminophen but not other analgesics, alcohol, coffee,tea, or smoking. Dig Dis Sci 1988; 33: 641-648.89
38. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer.Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J ClinGastroenterol 1997; 24: 2-17. 39. Huang JQ, Sridhar S, Hunt RH. Role ofHelicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcerdisease: a meta-analysis. Lancet 2002; 359: 14-22.40. Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T et al. Eradication ofHelicobacter pylori and risk of peptic ulcers in patients starting long-term treatmentwith non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359: 9-13.41. Straus WL, Ofman JJ, MacLean C, Morton S, Berger ML, Roth EA et al. DoNSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsiadefinitions. Am J Gastroenterol 2002; 97: 1.951-1.958.42. Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosalinjury. Best Pract Res Clin Gastroenterol 2001; 15: 705-722.43. The National Prescribing Center. Managing dyspepsia: the role of Helicobacterpylori. MeReC Bulletin 2001; 12 (1): 1-4.44. Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D et al.Relation of adult lifestiles and socioeconomic factors to the prevalence ofHelicobacter pylori infection. Int J Epidemiol 2002; 31: 624-631.45. Goodwin RD, Murray BS. Generalized Anxiety disorder and peptic ulcer diseaseamong adults in the United States. Psychosomatic Medicine 2002; 64: 862-866.46. Andersen IB, Jorgensen T, Bonnevie O, Gronbaek M, Sorensen TI. Smoking andalcohol intake as risk factors for bleeding and perforated peptic ulcers: a populationbasedcohort study. Epidemiology 2000; 11: 434-439.47. International Agency for Research on Cancer. Infection with Helicobacter pylori.IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-240.48. Correa P. Gastric neoplasia. Curr Gastroenterol Rep 2002; 4: 463-470.49. Priebe WM, DaCosta LR, Beck IT. Is epigastric tenderness a sign of peptic ulcerdisease? Gastroenterology 1982; 82: 16-19.50. Numans ME, Van der Graaf Y, de Wit NJ, Touw-Otten F, de Melker RA. Howmuch ulcer is ulcer-like? Diagnostic determinants of peptic ulcer in open accessgastroscopy. Fam Pract 1994; 11: 382-388.51. Johannessen T, Petersen H, Kleveland PM, Dybdahl JH, Sandvik AK, Brenna Eet al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990; 25:689-697.52. Muris JW, Starmans R, Pop P, Crebolder HF, Knottnerus JA. Discriminant valueof symptoms in patients with dyspepsia. J Fam Pract 1994; 38: 139-143.53. Bytzer P, Hansen JM, Havelund T, Malchow-Moller A, Schaffalitzky de MuckadellOB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinicaljudgement. Eur J Gastroenterol Hepatol 1996; 8: 359-363.90
Page 2:
INSTITUTO GUATEMALTECO DE SEGURIDAD
Page 5 and 6:
Los grados de recomendación son cr
Page 7 and 8:
Las GPC ayudan a los profesionales
Page 9 and 10:
2.11.3. Medidas higiénico-dietéti
Page 11 and 12:
GUÍA DE BOLSILLO de Enfermedad Pé
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
1 INTRODUCCIÓN1.1. ANTECEDENTESLa
Page 21 and 22:
1.3. OBJETIVOS1.3.1. Proporcionar i
Page 23 and 24:
2 CONTENIDO2.1. DEFINICIÓN Y TERMI
Page 25 and 26:
Así mismo, la incidencia del cánc
Page 27 and 28:
Los trastornos psicológicos y psiq
Page 29 and 30:
2bA partir de la historia clínica,
Page 32 and 33:
Estos modelos, construidos mediante
Page 34 and 35:
2.8.1. TRATAMIENTO EMPÍRICO ANTISE
Page 36 and 37:
2.8.3. INVESTIGACIÓN DE LA INFECCI
Page 38 and 39:
Estos aspectos ya fueron señalados
Page 40 and 41:
2.9. Técnicas y/o pruebas diagnós
Page 42 and 43:
Es necesario evitar la toma de fár
Page 44 and 45:
2.10.2.2. Si existen escalas de pun
Page 46 and 47:
Algoritmo 2. Manejo del paciente co
Page 48 and 49: El profesional sanitario puede ayud
Page 50 and 51: Se disponen de pocos ECA que compar
Page 52 and 53: Actualmente no se conoce cómo sele
Page 54 and 55: Algoritmo 3. Paciente con dispepsia
Page 56 and 57: 2.12.2. PAUTAS PARA LA ERRADICACIÓ
Page 58 and 59: Como tratamiento erradicador de seg
Page 60 and 61: En la úlcera gástrica2.12.7. ÚLC
Page 62 and 63: 2.12.9.11. Si una vez finalizado el
Page 64 and 65: Algoritmo 4. Paciente con úlcera d
Page 66 and 67: 3 INFORMACIÓN PARA EL USO RACIONAL
Page 68 and 69: Subgrupo Efectos Adversos Contraind
Page 70 and 71: Subgrupo Efectos adversos Contraind
Page 72 and 73: 4 AnexosIDESCRIPCIÓN DE LA REVISI
Page 74 and 75: Valor diagnóstico de la dispepsia.
Page 76 and 77: IINIVELES DE EVIDENCIA Y GRADOS DE
Page 78 and 79: Estudios de historia natural y pron
Page 80 and 81: DiagnósticoGrado derecomendaciónA
Page 82 and 83: IIIDEFINICIONES DE ENTIDADES Y TÉR
Page 84 and 85: IVPRUEBAS PARA LA DETECCIÓN DEL HE
Page 86 and 87: VSIGNIFICADO CLÍNICO DE LOS HALLAZ
Page 88 and 89: VIFACTORES FACILITADORES Y BARRERAS
Page 90 and 91: VIIIINFORMACIÓN PARA PACIENTES¿QU
Page 92 and 93: ¿QUÉ TRATAMIENTO HE DE REALIZAR?E
Page 94 and 95: XDIRECCIONES DE INTERÉS EN INTERNE
Page 96 and 97: XI REFERENCIAS BIBLIOGRÁFICAS© Ma
Page 100 and 101: 54. Hansen JM, Bytzer P, Schaffalit
Page 102 and 103: 84. Breslin NP, Thomson AB, Bailey
Page 104 and 105: 114. Ghosh S, Kinnear M. Dyspepsia
Page 106 and 107: 142. Delaney BC, Wilson S, Roalfe A
Page 108 and 109: 173. Soo S, Moayyedi P, Deeks J, De
Page 110 and 111: 202. Delaney B, Moayyedi P, Forman
Page 112 and 113: 228. Fischbach LA, Goodman KJ, Feld
show all

manejo del paciente con dispepsia - Instituto Guatemalteco de ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?